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Previous studies have shown that expression of the heparan sulfate proteoglycan, perlecan, on the external trophectodermal
cell surfaces of mouse blastocysts increases during acquisition of attachment competence. However, it is not clear if this
change in perlecan protein expression also is re¯ected at the level of perlecan mRNA expression. In the present investigation,
the spatial and temporal patterns of perlecan mRNA expression in the mouse embryo during the periimplantation period
were examined by in situ hybridization and reverse transcriptase±polymerase chain reaction. In addition, a delayed implan-
tation model was used to determine the expression of perlecan mRNA and protein in dormant and estrogen-activated
hatched blastocysts. The results demonstrate that perlecan mRNA expression is low in morulae, but increases in Day 4
blastocysts, attaining maximal expression in Day 4.5 attachment-competent blastocysts. In contrast, perlecan mRNA is
detected in both the dormant and estrogen-activated delayed blastocysts; however, within 12 hr of blastocyst activation
by estrogen, both perlecan protein and heparan sulfate chain expression markedly increase. Taken together, these results
suggest that during normal development perlecan mRNA expression increases with the acquisition of attachment compe-
tence. Moreover, perlecan protein expression also is attenuated during delayed implantation and appears to increase in
response to nidatory estrogen, perhaps via the increased translation of preexisting perlecan mRNA. q 1997 Academic Press
INTRODUCTION or the presence of soluble HS competitors all delayed blasto-
cyst attachment to a variety of matrices including laminin,
®bronectin, and uterine epithelial cells (Farach et al., 1987,Successful implantation is dependent upon an intimate
1988). It has also been demonstrated that mouse and human``cross-talk'' between the embryo and the uterus. Once the
uterine epithelial cells express complementary HS bindingblastocyst hatches from the zona pellucida, its trophecto-
proteins that may aid in blastocyst attachment (Wilson etderm becomes attachment competent, i.e., gains the ability
al., 1990; Raboudi et al., 1992; Liu et al., 1996; Rohde etto attach to the uterine luminal epithelium. At the same
al., 1996). Recently, the HSPG, perlecan, has been identi®edtime, the uterus must be in a ``receptive'' state for successful
at the sites of blastocyst apposition in the uterus in vivoimplantation to occur. The attainment of the receptive state
(Carson et al., 1993). Perlecan is a 400-kDa protein com-of the uterus is primarily regulated by ovarian estrogen and
monly found in the basal lamina underlying epithelial cells.progesterone (Psychoyos, 1986). A role for heparin/heparan
Of the ®ve domains in perlecan, the amino terminus issulfate proteoglycans (HSPGs) in mouse embryo attachment
unique, including attachment sites for HS chains. In addi-has been suggested (see review Carson et al., 1994). Synthe-
tion, there is no transmembrane domain (Noonan, et al.,sis of HSPGs increases on the murine embryonic cell surface
1991). Since perlecan expression on the cell surface of blas-during the periimplantation period (Farach et al., 1987). In-
tocysts increases during acquisition of attachment compe-hibition of embryonic proteoglycan synthesis, speci®c re-
tence, it is possible that this proteoglycan is one of themoval of heparan sulfate (HS) from blastocyst cell surfaces,
HSPG mediators of trophectoderm±luminal epithelial cell
attachment. However, it is not clear if the perlecan gene is
expressed coordinately with the increase in perlecan protein1 To whom correspondence should be addressed.
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Slides were examined under a dissecting scope for the presence ofunder these conditions. In order to expand on previous stud-
embryos, allowed to air dry, and held on dry ice until all the em-ies, in situ hybridization was used to determine the spatial
bryos had been processed. Slides containing embryos were storedand temporal expression of perlecan mRNA in periimplan-
at 0707C until ready for use. For immuno¯uorescence or in situtation embryos. In mice and other species, implantation
hybridization, embryos were processed the same as tissue sections.may be delayed either naturally or experimentally (Yoshi-
Delayed implantation. To determine whether perlecan mRNA
naga and Adams, 1966). Therefore, it was of interest to deter- is induced in response to nidatory estrogen, an experimentally de-
mine if HSPG expression also is delayed in blastocysts under layed implantation model was used (Yoshinaga and Adams, 1966;
these conditions. Using an experimentally delayed implan- Paria et al., 1992). To maintain blastocysts in a state of delay,
tation model, we examined the effects of nidatory estrogen pregnant mice were ovariectomized on the morning of Day 4 (0800±
0900 hr) and injected subcutaneously with progesterone (2 mg peron perlecan expression in activated blastocysts and dormant
mouse) on Days 5, 6, and 7. During the period of delay, blastocystsblastocysts. The results indicate that increased perlecan pro-
hatch, but remain unattached. To initiate blastocyst activation andtein expression may result either from increased mRNA
implantation, mice were coinjected with estradiol-17b (25 ng perexpression (normal implantation) or by increased transla-
mouse) and progesterone on Day 7 of pregnancy (Huet-Hudson andtion of preexisting mRNA (delayed implantation). Collec-
Dey, 1990). Embryos were ¯ushed from the uterus 12 and 24 hrtively, these data further demonstrate that increased HSPG
post-estradiol injection, cytospun onto slides, and assessed for the
expression at multiple levels is tightly associated with ac- presence of perlecan protein and mRNA as described below. Each
quisition of blastocyst attachment competence. experiment was performed at least two to three times on separate
preparations of embryos (10±15 embryos per preparation).
Indirect immuno¯uorescence staining of implantation sites in
utero. To assess the stage of embryonic development, one uterineMATERIALS AND METHODS
horn was ¯ushed and the other uterine horn was snap frozen in a
dry ice/isopentane bath and stored at 0807C until sectioned. To
Materials. CF-1 mice were obtained from Sasco (Omaha, NE). establish whether embryos were hatched, 7-mm sections of uteri
Tissue-Tek O.C.T. was purchased from Miles Inc. (Elkhart, IN). containing blastocysts were probed with antibodies to zona pellu-
Rabbit antibody to human basic ®broblast growth factor (bFGF) cida (ZP) proteins 2 and 3 and tenascin as previously described
was purchased from Collaborative Research, Inc. (Bedford, MA). (Julian et al., 1994). Detection of ZP2/ZP3 indicated that the blasto-
Species-speci®c ¯uorescein-conjugated rhodamine-conjugated sec- cyst was still encapsulated by the ZP and unhatched. The absence
ond antibodies to rabbit and rat IgG were obtained from Amersham of ZP2/ZP3 and the presence of tenascin, an extracellular matrix
Corporation (Arlington Heights, IL). Rat anti-heparan sulfate pro- protein induced in subepithelial stroma, were used as markers for
teoglycan (perlecan) monoclonal antibody was purchased from hatched, attachment-competent blastocysts (Julian et al., 1994).
Chemicon International Inc. (Temecula, CA). The mouse perlecan Indirect immuno¯uorescence localization of perlecan core pro-
DNA, clone 5, was a generous gift from Dr. John Hassell (Eye and tein and detection of heparan sulfate chains by bFGF binding.
Ear Institute, Pittsburgh, PA). The in vitro transcription kit was The procedure for the indirect immuno¯uorescence localization of
obtained from Ambion (Austin, TX), and the [a-35S]UTP (1000 perlecan core protein and detection of heparan sulfate chains was
Ci/mmole) from DuPont (Wilmington, DE). RNase A, restriction performed as previously described (Carson et al., 1993). In the pres-
enzymes, and yeast RNA were purchased from Boehringer-Mann- ent study, a rat anti-perlecan monoclonal antibody was used. In
heim Biochemicals (Indianapolis, IN). Ultrapure phenol was pur- agreement with earlier results, using the rabbit polyclonal anti-
chased from Gibco BRL (Gaithersburg, MD) and formamide from body, the rat monoclonal antibody recognized perlecan in sections
Fluka (Ronkonkoma, NY). All other reagents used in this study from Day 4.5 implantation sites in the basal lamina, in extracellular
were of reagent grade or better. matrix surrounding uterine stroma, and between uterine epithe-
Embryo collection. Female mice were injected intraperitone- lium and trophectoderm of hatched blastocysts (data not shown).
ally with 5 IU of pregnant mare serum gonadotropin and 48 hr later These experiments were performed on at least 10 different implan-
with 5 IU of human chorionic gonadotropin (hCG). Following hCG tation sites. For double labeling of cytospun embryos with both
injection females were caged with males of proven fertility. Fe- bFGF and anti-perlecan, embryos were ®xed 10 min in 100% meth-
males were examined the following morning for the presence of a anol and incubated with bFGF for 2 hr at 377C. Upon application
vaginal plug indicating Day 1 of pregnancy. It has been shown in of the anti-bFGF, the anti-perlecan also was added. Embryos were
previous studies (Carson et al., 1993) that uteri collected from mice processed as mentioned previously. FITC donkey anti-rabbit and
in our colony at 96 hr post-hCG injection and ¯ushed with Hanks' RITC donkey anti-rat secondary antibodies were applied together.
balanced salt solution contain approximately 80% unhatched blas- Riboprobe preparation. Linearized DNA clone (clone 5 in
tocysts. However, approximately 80% of the blastocysts are Noonan et al., 1988) for mouse perlecan in Bluescript (SK//0) vector
hatched when recovered 108 hr post-hCG injection. Using the go- (Stratagene) was used. Approximately 1 mg of linearized template
nadotropin injection regimen described above, embryos were DNA was used to generate sense and antisense riboprobes. The
¯ushed from the reproductive tract during three developmental total reactivity incorporated into 35S-labeled cRNA probes obtained
time periods. Embryos were collected at 76 hr (Day 3 morula, un- using 1 mg of DNA as template along with RNA polymerase T3 or
hatched), 96 hr (Day 4 blastocysts, unhatched), and 108 hr (Day T7 was usually 0.3±1.4 1 108 dpm. The probes were puri®ed by
4.5 blastocysts, hatched) post-hCG injection. Zona pellucidae were phenol:chloroform extraction and ethanol precipitation. To en-
removed from unhatched embryos with acid Tyrode's solution hance probe penetration into the tissue, the pelleted probes were
(Gordon, 1993). hydrolyzed to approximately 100 nucleotides in the presence of 60
Cytospin collection of embryos. Ten to twelve embryos from mM Na2CO3 and 40 mM NaHCO3 , pH 10.2, as described by Cox
the time points stated above were transferred into a cytospin funnel et al. (1984). Riboprobes were recovered by ethanol precipitation
preloaded with 200 ml of Hanks' balanced salt solution and centri- and resuspended in 10 mM Tris±HCl (pH 7.5), 1 mM EDTA, and
10 mM dithiothreitol and stored at 0707C until use.fuged for 5 min at 2000 rpm in a Shandon Elliott tabletop centrifuge.
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In situ hybridization. Frozen serial sections of implantation 100 ml with the addition of 70 ml of 11 PCR buffer and 2.5 mM
MgCl2 and overlayered with 100 ml of mineral oil. Following a 1-sites and isolated embryos as described above were subjected to in
min incubation at 957C, 35 repeated cycles were carried out withsitu hybridization using protocols described previously (De et al.,
30 sec at 957C, 30 sec at 557C, and 30 sec at 727C followed by a1989; McMaster et al., 1992). Brie¯y, slides were removed from the
10-min ®nal extension at 727C. The PCR products were ethanol-0707C freezer, warmed to 377C for 1 min, and ®xed in 4% (w/v)
precipitated, resuspended in tracking dye gel buffer, and loaded onparaformaldehyde in PBS for 15 min. Following prehybridization,
a 5% nondenaturing polyacrylamide gel in 0.51Tris±borate EDTA150 ml of hybridization solution containing 2 1 107 cpm/ml was
buffer. The gel was dried and exposed to X-ray ®lm. The bandsadded to each sample and covered with a silconized coverslip. Hy-
were quanti®ed by scanning with a laser densitometer.bridization was carried out at 457C for 4 hr. Unhybridized probe
was digested with 20 mg/ml of RNase A at 377C for 15 min. Hybrid-
ized probe was detected after 2 weeks of autoradiography using
Kodak NTB-2 emulsion. Following development, slides were
RESULTSpoststained with hematoxylin and eosin. At least 20 embryos at
each developmental stage have been examined in these studies.
Isolation of total RNA. Total RNA was isolated from Day 4 Analysis of perlecan mRNA in mouse embryos by in situ
and Day 4.5 mouse blastocysts as described by Andrews et al. (1991) hybridization and RT±PCR during normal pregnancy.
with the following modi®cations: Blastocysts (80±100 per group) Previous in vivo and in vitro studies have demonstrated
were collected as described above, quick frozen on dry ice, and that perlecan protein is present on the exterior surface of
stored at 0707C. Embryos were allowed to thaw on ice and resus-
the trophectoderm during the attachment phase of implan-pended in SDS buffer, phenol saturated with SDS buffer, and 20 mg
tation (Carson et al., 1993). Since perlecan protein is presentyeast RNA. Included in the SDS buffer was 50,000 cpm of 35S-
after, but not before, the blastocyst hatches from the zonalabeled mouse b-actin RNA was used as a tracer to determine RNA
pellucida and becomes attachment competent, it was neces-recovery. Recovery of the tracer was determined by liquid scintilla-
sary to determine at which developmental stage mRNAtion counting of aliquots taken of the initial SDS buffer and the
®nal RNA solution. This mixture was homogenized by repeated encoding perlecan was ®rst expressed. It was anticipated
aspiration into a 27-gauge needle attached to a 1-cc syringe. To that perlecan mRNA could be expressed in the unhatched
reduce sample loss, care was taken to avoid pulling the homogenate embryo prior to the time of attachment competence. Ini-
into the syringe. The sample was chilled at 47C for 15 min and tially, unhatched (Day 4) and hatched (Day 4.5) embryos
spun for 10 min at 47C in an Eppendorf centrifuge. Following cen- developed in utero were examined by in situ hybridization.
trifugation, the organic layer was carefully removed and discarded. In uterine sections obtained from Day 4 pregnant mice,
The aqueous layer was reextracted with an equal volume of phe-
perlecan mRNA was uniformly expressed throughout thenol:chloroform:isoamyl alcohol (24:24:1) and centrifuged as de-
stromal compartment and abundantly expressed in thescribed above. After centrifugation, the aqueous layer was trans-
myometrial smooth muscle; however, no signal was appar-ferred to a 1.5-ml Eppendorf tube and 3 vol of 4 M ammonium
ent in the unhatched embryo (data not shown). Elevatedacetate and ethanol were added to precipitate RNA. RNA was al-
levels of perlecan mRNA were detected in the subepitheliallowed to precipitate overnight at 0707C. The RNA precipitate was
collected by spinning in an Eppendorf centrifuge for 30 min at 47C, stroma surrounding Day 4.5 hatched embryos (Fig. 1C). Ex-
and the pellet was washed with 80% ethanol, dried under vacuum pression in the peripheral portion of the stromal compart-
for 2 min, and dissolved in 10 ml of DEPC water. ment resembled that of Day 4. In contrast, expression of
Reverse transcriptase±polymerase chain reaction. The re- the perlecan transcript was negligible in uterine epithelial
verse transcriptase±polymerase chain reaction (RT±PCR) proce- cells. Sections of implantation sites probed with a cRNA
dure was performed with modi®cation of the procedure described sense probe detected only background hybridization signals,
by Wegner et al. (1995). RNA from 80 blastocysts was reverse tran- establishing the speci®city of the antisense probe (Fig. 1A).
scribed in a 20-ml volume containing 11 PCR buffer, 1 mM of each
Due to high levels of perlecan mRNA expression in thedNTP, 500 ng of poly(dT)12±18 , 4 mM MgCl2 , 20 units RNAsin RNA
endometrial stroma surrounding the implantation site andinhibitor, and 2.5 units of AMV reverse transcriptase. The reaction
thin cell bodies of trophectoderm in hatched blastocysts,was incubated at 427C for 75 min and was terminated by heating
uniform localization of the perlecan transcript was dif®cultat 957C for 5 min. The L19 primers were the same as those described
to obtain in sections of implantation sites. Therefore, in theby Wegner et al. (1995). The perlecan primers were: (forward) 5*-
CCTACGATGGCCTTTCCCTC and (reverse) 5*-TGGCACTTG- remainder of the studies, embryos were allowed to develop
CATCCTCCA and correspond to /83 to /102 and /299 to /316 in vivo and then ¯ushed from the uterus at different devel-
of the mouse perlecan DNA sequence (Noonan et al., 1988). The opmental stages to facilitate interpretation of in situ hybrid-
products obtained by use of the perlecan primers were of the ex- ization results for embryos.
pected size before and after restriction enzyme digestion. In addi- There was no signi®cant difference in grain densities be-
tion, no products were observed if RNA or reverse transcriptase tween morulae stage embryos probed with a sense or anti-
was omitted from the reaction, demonstrating that these products
sense perlecan cRNA probe (Figs. 2A, 2B, 3A). Perlecan
were not due to the presence of contaminating DNA. Partial se-
mRNA was initially detected at low levels in Day 4 un-quencing of the PCR products also con®rmed their identity. Ten
hatched blastocysts (Figs. 2C, and 2D). Hatching from themicroliters of PCR cocktail containing 11 PCR buffer, 60 pmole
zona pellucida in mice occurs between Days 4 and 4.5, aftereach of the perlecan and ribosomal protein L19 (internal control)
which the blastocysts become attachment competent. Asoligonucleotide primers, 2 mCi [a-32P]deoxy-CTP (3000 Ci/mmole),
shown in Fig. 2F, hatched blastocysts expressed high levelsand 2.5 units of Taq DNA polymerase were added to the DNA
generated above. The ®nal volume of the reaction was adjusted to of perlecan mRNA. The transcript was present in both the
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FIG. 1. Perlecan mRNA expression in Day 4.5 embryos detected by in situ hybridization. Dark-®eld (A, C) and corresponding bright-
®eld (B, D) photomicrographs of an implantation site in frozen uterine sections obtained from a Day 4.5 pregnant mouse. Sense cRNA
controls are shown in A and B and antisense cRNA was used in C and D. In situ hybridization using the sense probe does not show
localization to a speci®c region. Perlecan mRNA localization detected by the antisense probe is abundant in the stromal cells (s) subjacent
to the uterine epithelium surrounding the embryo (e).
mural and polar trophectoderm. These data indicate that closely accompanied acquisition of attachment competence
during normal embryonic development.perlecan mRNA expression increased closely following or
coincident with the process of hatching. To quantitate the Perlecan protein and mRNA expression in blastocysts
during delayed implantation. Given the results obtainedincrease in perlecan mRNA expression between unhatched
stage blastocysts and hatched blastocysts, the number of during normal pregnancy, it was of interest to determine
the consequences of implantation delay on perlecan mRNAsilver grains per embryo was counted for morulae, un-
hatched blastocysts, and hatched blastocysts, for both sense and protein expression. In this model, embryos hatch from
the zona pellucida, but do not become attachment compe-and antisense probes. The mean number of grains/embryo,
shown in Fig. 3A, indicates a signi®cant difference between tent until a nidatory dose of estrogen is administered. Ex-
pression of several other blastocyst genes is associated withthe hatched blastocyst stage embryo and all groups, with P
 0.0001. The relative increase in antisense probe hybrid- this activation event (Paria et al., 1992, 1993a,b). Immuno-
histochemical staining techniques were used to detect per-ization between unhatched (Day 4.0) and hatched (Day 4.5)
blastocysts was approximately sixfold. Similar results were lecan core protein and HS chain expression. Speci®city con-
trols included use of nonimmune ascites ¯uid versus ascitesobtained using an RT±PCR assay. RNA encoding a consti-
tutively expressed ribosomal protein, L19, was used as an ¯uid containing rat monoclonal IgG directed at perlecan
(compare Fig. 4, panels A and B) and predigestion of embryosinternal control as described previously (Wegner et al.,
1996). As shown in Fig. 3B, a marked (sevenfold) increase with heparinases to remove HS chains (Fig. 4, panels C and
D) or competition with excess heparin (Fig. 6, panels B andwas observed for perlecan mRNA relative to L19 transcript
between Day 4.0 (unhatched) and Day 4.5 (hatched, attach- D) for the HS detection technique. While it is possible that
bFGF might bind to components other than HS, the ef®cientment-competent) blastocysts. These results indicated that,
like perlecan protein, increased perlecan mRNA expression competition with heparin and inhibition of bFGF binding
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FIG. 2. In situ hybridization of perlecan mRNA in mouse embryos. In situ hybridizations of cytospun embryos were performed as
described under Materials and Methods. Localized hybridization was not observed in the embryos in A, C, and E probed with sense cRNA.
Perlecan mRNA, as detected by hybridization with antisense perlecan cRNA probe, was below detectable levels in Day 3 morulae (B),
began to appear in unhatched Day 4 blastocysts (D), and was maximally expressed in hatched Day 4.5 blastocysts (F), at a time when
initial adhesion to the uterus normally occurs in vivo. These experiments were repeated twice with 15 ±20 embryos each time from each
developmental stage. Embryos chosen for illustration are representative. Magni®cation, 2701.
by heparinase predigestion strongly suggest HS is the pre- tion. In contrast to protein expression, in situ hybridization
analysis demonstrated that the transcript for perlecan wasdominant bFGF ligand detected in these experiments.
Increased levels of perlecan protein were detected in blas- present in both dormant (Fig. 7B) and estrogen-activated
(Fig. 7D) blastocysts. As observed with normal blastocysts,tocysts at 12 hr (Fig. 5B) and 24 hr (Fig. 5C) after estradiol
activation compared to dormant embryos maintained on the transcript appeared to be present in the inner cell mass
as well as the mural trophectoderm. Again, an absence ofprogesterone alone (Fig. 5A). In addition to the perlecan core
protein, HS expression, as detected by bFGF staining (Sied- localized signal observed with a sense probe demonstrated
the speci®city of the antisense perlecan probe (Fig. 7F).lak et al., 1991), was elevated following estradiol activation,
with a similar temporal pattern (Fig. 6). Thus, both perlecan These data, together with those obtained with normally
implanting embryos, indicate that elevated expression ofcore protein and HS polysaccharide expression were ele-
vated in dormant blastocysts in response to estrogen activa- perlecan mRNA does not require estrogen activation. In
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FIG. 3. Quantitation of increase in perlecan mRNA expression. Cytospun embryos from in situ hybridization experiments were examined
by light microscopy and total silver grains on the embryos were counted for 10 ±30 embryos in each case (A). Morula, unhatched blastocyst
(Day 4.0), and hatched blastocyst (Day 4.5) stage embryos were examined with both sense and antisense probes. There is a signi®cant
difference, P  0.0001, between the number of grains on hatched blastocysts using the antisense probe and all other groups of embryos.
(B) RT±PCR analysis using unhatched blastocyst and hatched blastocyst RNA demonstrates a substantial increase in perlecan mRNA in
comparison to mRNA for the constitutively expressed ribosomal protein, L19. The ratio of intensity of Pln bands to L19 bands, as
determined by densitometry, was calculated as 0.09 for Day 4.0 embryos and 0.63 for Day 4.5 embryos. Approximately 60 embryos were
used for each analysis.
FIG. 4. Speci®city controls for detection of perlecan and heparan sulfate in blastocysts. Normal hatched blastocysts were cytospun and
probed with the rat antibody from ascites ¯uid to perlecan core protein (A), a rat ascites ¯uid control for the Pln antibody (B), recombinant
bFGF to detect HS chains as described under Materials and Methods (C), or with bFGF after predigestion of the embryos with heparinase
to remove HS chains (D). The signal present in the controls (B, D) is greatly decreased or absent versus that seen in the experimental
embryos (A, C), demonstrating the probes speci®city in both cases. Magni®cation, 4301.
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DISCUSSION
In the present study, we have established that perlecan
mRNA is initially detected in unhatched Day 4 blastocysts.
After hatching from the zona pellucida, the blastocysts be-
come attachment competent and perlecan mRNA is abun-
dantly expressed. This correlates with perlecan protein ex-
pression displayed on the trophectodermal surface of Day
4.5 blastocysts, but absent in Day 4 unhatched blastocysts
(Carson et al., 1993). Previous studies have detected extra-
cellular matrix components in early preimplantation em-
bryos prior to the formation of a basement membrane (see
review by Leivo, 1983). These components include collagen
IV, laminin, HSPG molecules, and nidogen (Leivo et al.,
1980; Sherman et al., 1980; Wu et al., 1983; Dziadek et al.,
1985; Dziadek and Timpl, 1985). After blastocyst formation,
discontinuous patches of collagen type IV and ®bronectin
are exhibited on the inner aspects of the mural trophecto-
derm (Leivo et al., 1980; Wartiovaara et al., 1979). It is possi-
ble that these proteins expressed on the inner trophecto-
dermal lining aid in the migration of parietal endoderm cells
which deposit Reichert's membrane. Consistent with this
view, we noted accumulation of perlecan mRNA in the
inner cell mass region. In addition to deposition in the blas-
tocyst interior, perlecan is present on the outer surface of
trophectoderm cells at the time of attachment competence
(Carson et al., 1993). The presence of this HSPG on the
outer surface of trophectoderm cells suggests a possible role
for perlecan in embryo±uterine attachment.
In normal developing blastocysts, both perlecan protein
(Carson et al., 1993) and mRNA increase markedly during
the transition from unhatched to hatched, attachment com-
petent blastocysts. During delayed implantation in vivo,
blastocysts hatch, but do not attach providing an additional
test of potential HSPG function in the implantation process.
It was of interest to determine if perlecan mRNA and pro-
tein were present in dormant blastocysts or induced in dor-
mant blastocysts activated by estrogen (Huet-Hudson and
Dey 1990; Paria et al., 1992). Under these conditions, we
detected perlecan protein in blastocysts 12 hr post-estrogen
injection, with maximal expression at 24 hr. Since HS
FIG. 5. Detection of perlecan core protein in delayed and activated chains on the surface of blastocysts may be involved in
mouse blastocysts by indirect immuno¯uorescence. Blastocysts
interacting with uterine cell surface components to aid em-collected during delay (A) or 12 (B) and 24 (C) hr after injection of
bryo adhesion with the luminal epithelium (see review Car-nidatory estradiol were cytospun and probed with an antibody to
son et al., 1994), we also determined whether HS chainsperlecan as described under Materials and Methods. Low levels
were correlated with the expression of perlecan protein. Re-of perlecan protein was detected in the progesterone-maintained,
sults from the present study indicate that both perlecandormant embryos, as shown in A; however, little de®nition of cell
peripheries was evident in these embryos and this pattern of stain- core protein and HS expression are elevated in delayed blas-
ing was similar to that observed with nonimmune rat IgG. In con- tocysts in response to estrogen. While it is possible that
trast, cell peripheries were evident in B and C, and the overall bFGF might bind to other ligands, e.g., FGF receptors, the
intensity of staining was markedly increased. Perlecan protein ex- heparinase digestion control (Fig. 4D) suggests that the ma-
pression increased within 12 hr of estrogen activation (B) and per- jority of bFGF is binding to HS chains, located on the amino
sisted through 24 hr (C). Original magni®cation, 4301.
terminus of the Pln core protein, or one of the HS chains
must interact with cell surface proteins. This would allow
the remaining HS chains to interact with bFGF. There is
contrast, enhanced expression of perlecan core protein, as also a possibility that the Pln core protein could be decor-
well as HS chains, requires additional developmental events ated with chondrotin sulfate (CS) chains or with no glycos-
aminoglycan chains at all (Couchman et al., 1996). Com-that can be triggered by estrogen stimulation.
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FIG. 6. Heparan sulfate (HS) chain expression increases in response to activation of dormant blastocysts. bFGF staining was used to
detect HS chain expression in cytospun, dormant, or estrogen-activated blastocysts, as described under Materials and Methods. The ®gure
shows staining of delayed embryos (A) and estradiol-activated (B and D, 12 hr; C, 24 hr) embryos incubated with bFGF in the absence (A,
B, C) or the presence (D) of 1 mg/ml heparin. Note the increased staining of the activated embryos at 12 (B) and 24 (C) hr post-estrogen
injection. This staining is markedly reduced by inclusion of heparin during the bFGF staining step (D). The staining observed in A and
D is comparable to that observed if bFGF was omitted from the staining procedures. Original magni®cation, 4301.
pared to HS, relatively little CS is synthesized at this stage slower rate of perlecan mRNA degradation in the dormant
blastocyst. This is in contrast to the ®nding of a rapid disap-of development (Farach et al., 1987). Furthermore, given the
coordinate increase in expression of perlecan mRNA and pearance of EGF receptor mRNA in the blastocyst coincid-
ing with the initiation of delayed implantation (Paria et al.,protein with the HS chains on the blastocyst surface, it
seems likely that, in this instance, Pln is decorated with 1993a).
The expression of an HSPG molecule on the surface ofHS chains.
In contrast, perlecan mRNA was expressed in blastocysts attachment-competent blastocysts at the time of implanta-
tion suggests a role for this molecule in implantation. Atmaintained in delay and was, therefore, present prior to
estrogen activation and protein expression. Following acti- the time embryos become attachment competent, the
uterus must also be in a state of receptivity for implantationvation, perlecan mRNA was still present in the inner cell
mass and trophectoderm of activated blastocysts. Since per- to occur (Psychoyos, 1986; Paria et al., 1993b). Interactions
between the trophectoderm and uterine luminal epitheliallecan mRNA is present prior to nidatory estrogen and per-
lecan protein expression increases after nidatory estrogen, cells are critical for attachment in all species (Enders and
Schlafke, 1974). Recently, the heparin binding EGF-likeit appears that perlecan may be subject to translational regu-
lation. However, it is not clear whether the accumulation growth factor (HB-EGF) gene was found to be locally in-
duced in mouse uterine luminal epithelial cells at the sitesof perlecan mRNA was due to continued transcription or a
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HS chains of perlecan, promoting attachment and stimulate
embryonic development. Description of HSPG expression
in mouse embryos may provide a model to determine the
precise role of these molecules in the implantation process.
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